(Presolicitation Notice) Intent to Sole Source - Biol Specimens for Lenacapavir PEP
PR97866 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A MEDICAL LABORATORIES solicitation, performed in Atlanta, GA, with responses due 2026-09-17. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Emory University for the procurement and delivery of biological specimens from persons receiving weekly oral lenacapavir. Emory maintains established HIV clinical-research infrastructure,
Comparable recent awards in MEDICAL LABORATORIES
| Winner | Award value | Offers | Date |
|---|---|---|---|
| TESTUDO LOGISTICS LLC | $269K | n/a | 2026-07-02 |
| TESTUDO LOGISTICS LLC | $269K | 1 | 2026-07-02 |
| UNIVERSITY OF COLORADO HOSPITAL AUTHORITY | $381K | n/a | 2026-06-30 |
| QUEST DIAGNOSTICS INCORPORATED | $4.1M | 1 | 2026-06-30 |
| MEMORIAL HOSPITAL OF LARAMIE COUNTY | $200K | 1 | 2026-06-30 |
Questions
What is solicitation PR97866?
(Presolicitation Notice) Intent to Sole Source - Biol Specimens for Lenacapavir PEP, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 621511 (MEDICAL LABORATORIES), performed in Atlanta, GA. Responses are due 2026-09-17.
What do similar contracts close for?
Comparable closed awards in this category ran from $200K to $4.1M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is PR97866 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.